Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Brain Tumor Trials Finder is a clinical trial search website for patients with neurological tumors. Its goal is to help patients with brain tumors, spinal cord tumors, and related conditions discover relevant clinical trials and research opportunities in the United States. The site is built with input from neuro-oncology physicians and front-end/UX developers, and its data comes from ClinicalTrials.gov, which is maintained by the U.S. National Library of Medicine.
Based on the available crawled content, its core feature is clinical trial search. Users can filter by tumor type, diagnosis type (newly diagnosed or recurrent), and distance range (10 to 500 miles or nationwide). It also offers mutation filters and a “My Saved Studies” feature. The product integrates Google Maps API, suggesting that it provides a location- and distance-based trial discovery experience. Overall, it is positioned more as a patient-facing vertical search tool than a traditional enterprise SaaS product.
The site does not disclose paid plans, subscription models, payment methods, free trials, or an enterprise purchasing process, so its commercialization model is unclear. In terms of third-party integrations, the text explicitly mentions ClinicalTrials.gov as the data source and Google Maps API for map-related functionality. The development stack includes Next.js, SCSS, and Adobe Creative Suite, but there is no indication that it offers an open API, developer documentation, or self-hosted deployment.
The website states that it is committed to protecting the privacy and security of user information, but it does not provide further details on HIPAA, SOC 2, encryption, access controls, data retention, or other compliance and security measures. It also clearly states that it does not screen, review, or approve the listed clinical trials, and that patients should consult medical professionals before deciding whether to participate. This disclaimer helps reduce the risk of misuse, but it also means the platform does not provide clinical recommendations or quality endorsements.
Its strengths are its focus on brain tumor clinical trials, patient-relevant filtering options, authoritative data source, and U.S. coverage. Its limitations include a narrow geographic scope and a lack of information on enterprise permissions, team collaboration, compliance, and support. It is suitable for U.S. brain tumor patients, family members, and physicians who want to initially identify research opportunities, but it is not suitable as a hospital clinical trial management system or an enterprise-grade patient recruitment platform.
The crawled text does not provide information about access from China. Since its core data and location services are U.S.-focused, its direct value for patients in China is limited. Possible alternatives include ClinicalTrials.gov, clinical trial center pages from domestic hospitals, China’s drug clinical trial registration and information disclosure platform, and clinical trial matching services provided by specialized medical institutions.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on braintumortrials.com official site.
braintumortrials.com is an United States Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach braintumortrials.com directly.